Business Context and Reporting Period
This Form 8-K filing by Glucotrack, Inc. (GCTK) is dated May 21, 2024, and addresses critical developments regarding the company's continued listing on The Nasdaq Stock Market LLC. The report details the company's failure to meet specific Nasdaq listing standards despite a prior reverse stock split and an extended compliance period.
Key Financial Metrics and Listing Status
The filing does not provide specific revenue, profit, or cash flow figures for the current period. However, it references the company's Form 10-Q for the period ended March 31, 2024, to highlight two specific financial deficiencies:
- Minimum Bid Price: The company failed to maintain the required minimum bid price of $1.00 per share.
- Minimum Stockholders' Equity: The company no longer meets the $2,500,000 minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
Material Changes and Corporate Actions
Significant events and changes reported include:
- Reverse Stock Split: On May 17, 2024, the company effected a one-for-five (1:5) reverse stock split in an attempt to regain compliance with the Minimum Bid Price Requirement.
- Compliance Failure: Despite the reverse split and an extended compliance period ending May 20, 2024, Nasdaq notified the company on May 21, 2024, that it had not regained compliance with the Minimum Bid Price Requirement.
- Delisting Notice: Nasdaq identified a separate failure to meet the Minimum Stockholders' Equity Requirement, creating an additional basis for delisting.
Outlook, Risks, and Management Commentary
Management has taken the following actions and outlined the following risks:
- Appeal Process: The company has timely requested a hearing before a Nasdaq Hearings Panel. This request stays any suspension or delisting action pending the hearing.
- Proposed Plan: At the hearing, the company intends to request a 180-day extension to raise additional capital to meet the Minimum Stockholders' Equity Requirement.
- Immediate Risk: Without a successful appeal or extension, trading of the common stock is scheduled to be suspended at the opening of business on May 30, 2024.
- Uncertainty: The filing explicitly states there can be no assurance that the Panel will grant the request for continued listing or that the company will be able to evidence compliance.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel regarding the request for a 180-day extension.
- Monitor the company's ability to raise capital to meet the $2,500,000 stockholders' equity requirement.
- Check for any suspension of trading on May 30, 2024, if the appeal is unsuccessful.
- Review the Form 10-Q for the period ended March 31, 2024, for detailed financial statements regarding the equity shortfall.